Shane Olwill is Chief Development Officer at PIERIS PHARMACEUTICALS, INC. (PIRS). They have made 1 open-market trade across 1 company since 2021, most recently 2021-08-30.
CIK 0001875416
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PIRS | 33,838 | $460K |
Shares reported on the most recent Form 4, priced at the 2021-09-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PIRS | SELL | 2021-08-30 | 2021-09-01 | $5.11 | $196K | +0.5% | -3.9% | -39.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.